Implementation of point-of-care molecular testing for respiratory viruses in congregate living settings.
Charlie Tan, Christina K Chan, Marianna Ofner...
https://pubmed.ncbi.nlm.nih.gov/38659123Actively Recruiting
Led by Michael Garron Hospital · Updated on 2025-12-02
24
Participants Needed
2
Research Sites
43 weeks
Total Duration
M
Michael Garron Hospital
Lead Sponsor
S
Sunnybrook Health Sciences Centre
Collaborating Sponsor
Researchers are evaluating whether faster testing for respiratory viruses like Influenza, COVID-19, and Respiratory Syncytial Virus (RSV) can reduce the number and size of virus outbreaks in long-term care homes. The trial compares rapid point-of-care testing with existing laboratory testing methods to see if quicker results help control virus spread among residents. This study is led by Michael Garron Hospital and involves long-term care facilities linked to specific Ontario Health Teams. The study involves two groups: one uses a point-of-care respiratory test platform located within the care facility to provide quick test results, while the other group continues using the existing respiratory virus testing platforms. The rapid testing device aims to deliver results faster than traditional lab methods, potentially allowing for timely infection control measures. The study is randomized and does not include blinding. Participants are long-term care residents in facilities engaged with Ontario Health Teams overseen by Sunnybrook Health Science Centre, Michael Garron Hospital, or Humber River Health. Researchers will track the number of residents infected with the targeted viruses over seven months, along with outbreak frequency, hospital transfers, deaths, outbreak duration, and secondary attack rates. No study blinding is used, and the trial runs until March 2026, monitoring outcomes at various intervals from 14 days to 60 days depending on the measure.
CONDITIONS
Respiratory Outbreak Mitigation in Long-Term Care Using Point-of-Care Testing
You may qualify if you...
You will not qualify if you...
Complete this quick 3-step screening to check your eligibility
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 7 months
Participants receive a point-of-care respiratory test platform or an existing respiratory virus testing platform as part of the trial to provide rapid test results within long-term care facilities.
Ongoing testing and monitoring during the trial period
Duration - 7 months
Participants are monitored for respiratory virus infections and outbreaks within the long-term care facilities.
Regular observation without additional visits
Total: 2 locations
1
Michael Garron Hospital
Toronto, Ontario, Canada, M4C 3E7
Actively Recruiting
2
Sunnybrook Health Sciences Centre
Toronto, Ontario, Canada, M4N 3M5
Actively Recruiting
C
Christopher Kandel, MD, PhD
J
Jerome Leis, MD, MSc
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
HEALTH_SERVICES_RESEARCH
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Charlie Tan, Christina K Chan, Marianna Ofner...
https://pubmed.ncbi.nlm.nih.gov/38659123